The content on this site is intended for healthcare professionals only
Dr Lazar speaks with ecancer at AACR 2017 about what the WIN symposium offers, how it compares to other oncology meetings taking place around the globe, and what innovations he foresees in cancer treatment.
He highlights the globally co-operative attitude of WIN consortium, reflected in the theme of this years conference, and introduces some key speakers.
Dr Lazar notes room for improvement in streamlining early diagnosis and delivering the latest therapies to clinics globally, and considers the future indications of combination therapies.
For more about the WIN consortium click here, or watch interviews from last year's symposium here.
Social determinants and survival outcomes in early-onset colorectal cancer in the US
The added value of integrative medicine
Multiple myeloma In Rwanda: The need for further research
Addressing the rise of multiple myeloma in Rwanda
GIST tumours and soft tissue sarcomas
Best practice in HRRm testing in patients with metastatic prostate cancer
Genomic testing: Awareness and effective communication between healthcare professionals and patients
The Southeast Asian Breast Cancer Symposium; background, aims and successes
Social determinants of health in primary care
